G1 Therapeutics, Inc. (GTHX)

Last Three Months

19-Feb-24 -- 18-May-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

3

(1)

21

0

3

+1

0

+2

0

+3

Two Year Chart

19-May-22 -- 18-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
15-May-24 4:10 PM View:	13-May-24 Sale ($39.03K)	Murdock Terry L Chief Operating Officer		G1 Therapeutics, Inc. - GTHX	(8%) 103.64K to 95.49K	0	0	--	--	Show Txns Hide Txns

15-May-24 4:07 PM View:	13-May-24 Sale ($39.03K)	Avagliano Mark Chief Business Officer		G1 Therapeutics, Inc. - GTHX	78% 117.83K to 209.68K	0	0	--	--	Show Txns Hide Txns

15-May-24 4:06 PM View:	13-May-24 Sale ($178.42K)	Bailey John E. (jack) Jr. President and CEO Director		G1 Therapeutics, Inc. - GTHX	(8%) 489.59K to 452.34K	0	0	--	--	Show Txns Hide Txns

15-May-24 4:08 PM View:	13-May-24 Sale ($39.03K)	Malik Rajesh Chief Medical Officer		G1 Therapeutics, Inc. - GTHX	(5%) 169.94K to 161.79K	0	0	--	--	Show Txns Hide Txns

15-May-24 10:00 PM View:	13-May-24 Sale ($39.03K)	Perry Andrew Chief Commercial Officer		G1 Therapeutics, Inc. - GTHX	(9%) 87.1K to 78.95K	0	0	--	--	Show Txns Hide Txns

15-May-24 4:11 PM View:	13-May-24 Sale ($39.03K)	Umstead John V. Chief Financial Officer		G1 Therapeutics, Inc. - GTHX	17% 130.44K to 153.25K	0	0	--	--	Show Txns Hide Txns

22-Mar-24 4:10 PM View:	20-Mar-24 Grant 0	Thomas Monica R. General Counsel		G1 Therapeutics, Inc. - GTHX	48% 78.15K to 115.65K	0	0	--	--	Show Txns Hide Txns